![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-1a613d9723b9b33d6cf62dcd0635116eef8d98351131687198e1679cbb453cb8.jpg)
Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions: Clinical Effectiveness
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.